Clinical Trial Detail

NCT ID NCT04321954
Title Lenvatinib in Locally Advanced Invasive Thyroid Cancer
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Massachusetts Eye and Ear Infirmary
Indications

thyroid gland cancer

thyroid gland papillary carcinoma

thyroid gland Hurthle cell carcinoma

thyroid gland follicular carcinoma

Therapies

Lenvatinib

Age Groups: adult senior

No variant requirements are available.